Acute Lymphoblastic Leukemia

Clinical trial landscape

660 registered studies reference this disease. The split below shows how many are ongoing versus completed per phase.

Phase	Total	Ongoing	Completed
Phase 2	176	58	75
Unknown	124	39	54
Phase 1	116	35	48
Phase 1/2	73	29	22
Not applicable	69	23	34
Phase 3	41	8	24
Phase 4	27	6	11
Phase 2/3	17	5	6
Early Phase 1	17	11	3
All phases	660	214	277

Ongoing Completed Balance withdrawn, terminated, or status unreported.

08 Aug 26	CAR-T Therapy Expands Beyond Cancer: Ireland Milestone, New Trials and Genetic Insights	nature.com ↗
08 Aug 26	FDA Approves Orca-T (Tregzi), First Regulatory T Cell-Based Immunotherapy to Prevent Chronic GVHD	ajmc.com ↗
21 Jul 26	FDA Approves Tregzi Cell Therapy to Prevent Chronic GVHD in Blood Cancer Patients	medicalxpress.com ↗
20 Jul 26	FDA Approves Orca-T (Tregzi) for Matched Donor HSCT in Hematologic Malignancies	onclive.com ↗
03 Jul 26	ASH Publishes Clinical Practice Guidelines for ALL in Adolescents and Young Adults	nature.com ↗
17 Jun 26	First Exercise Recommendations for Pediatric Cancer Patients Published; Clinical Trial Launches for Young Sarcoma Care	ascopost.com ↗
23 Apr 26	WHO targets child-friendly cancer drug formulations amid treatment gap	nature.com ↗
22 Apr 26	Ascentage Pharma to present ASCO clinical data and AACR preclinical studies in 2026	biospace.com ↗
03 Apr 26	Engineered Immune Cells and Targeted Antigens Advance Cancer Immunotherapy	news-medical.net ↗
21 Mar 26	AI Tools Accelerate Cancer Drug Testing and Clinical Trial Enrollment	cancernetwork.com ↗

Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.